From: Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
Age group | IPD | Inpatient CAP | Outpatient CAP | |||
---|---|---|---|---|---|---|
 | Incidence | CFR | Incidence[[22]] | CFR[[25]] | Incidence[[24]] | CFR# |
18 - 39 | 0.5 | 14.9% # | 48.9 | 1.6% | 574.7 | 0.0% |
40 - 49 | 6.8 | 14.9% # | 80.4 | 4.3% | 777.3 | 0.0% |
50 - 59 | 13.3 | 14.9% # | 149.7 | 6.3% | 1,074.0 | 0.5% |
60 - 69 | 23.0 | 14.9% # | 350.4 | 10.8% | 1,459.3 | 0.5% |
70 - 79 | 41.6 | 16.5% | 768.7 | 16.8% | 1,465.8 | 0.5% |
80+ | 53.7 | 27.4% | 1,897.8 | 22.6% | 2,025.2 | 0.5% |